These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 19002127)

  • 1. Sacral neuromodulation for urinary retention.
    Kessler TM; Fowler CJ
    Nat Clin Pract Urol; 2008 Dec; 5(12):657-66. PubMed ID: 19002127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The presence of Fowler's syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention.
    De Ridder D; Ost D; Bruyninckx F
    Eur Urol; 2007 Jan; 51(1):229-33; discussion 233-4. PubMed ID: 16860462
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary retention in women and sacral neuromodulation.
    Elneil S
    Int Urogynecol J; 2010 Dec; 21 Suppl 2():S475-83. PubMed ID: 20972545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fowler's Syndrome: diagnostic and therapeutic challenge].
    Bártolo M; Martins L; Martins F
    Acta Med Port; 2011; 24(4):645-8. PubMed ID: 22521026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urodynamic study of women in urinary retention treated with sacral neuromodulation.
    DasGupta R; Fowler CJ
    J Urol; 2004 Mar; 171(3):1161-4. PubMed ID: 14767292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience.
    Spinelli M; Giardiello G; Gerber M; Arduini A; van den Hombergh U; Malaguti S
    J Urol; 2003 Nov; 170(5):1905-7. PubMed ID: 14532804
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of sacral neuromodulation for women with urinary retention.
    Dasgupta R; Wiseman OJ; Kitchen N; Fowler CJ
    BJU Int; 2004 Aug; 94(3):335-7. PubMed ID: 15291863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sacral neuromodulation for treating the symptoms of overactive bladder syndrome and non-obstructive urinary retention: >10 years of clinical experience.
    Chartier-Kastler E
    BJU Int; 2008 Feb; 101(4):417-23. PubMed ID: 18070181
    [No Abstract]   [Full Text] [Related]  

  • 9. Sacral neuromodulation for nonobstructive urinary retention--is success predictable?
    Goh M; Diokno AC
    J Urol; 2007 Jul; 178(1):197-9; discussion 199. PubMed ID: 17499773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term results of sacral neuromodulation with the tined lead procedure.
    Marcelissen TA; Leong RK; de Bie RA; van Kerrebroeck PE; de Wachter SG
    J Urol; 2010 Nov; 184(5):1997-2000. PubMed ID: 20850820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention.
    Shaker HS; Hassouna M
    J Urol; 1998 May; 159(5):1476-8. PubMed ID: 9554336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Sacral neuromodulation in under- and overactive detrusor-quo vadis? : Principles and developments].
    Girtner F; Burger M; Mayr R
    Urologe A; 2019 Jun; 58(6):634-639. PubMed ID: 31139864
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Latest technologic and surgical developments in using InterStim Therapy for sacral neuromodulation: impact on treatment success and safety.
    Spinelli M; Sievert KD
    Eur Urol; 2008 Dec; 54(6):1287-96. PubMed ID: 18336992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolonged percutaneous SNM testing does not cause infection-related explanation.
    Amend B; Bedke J; Khalil M; Stenzl A; Sievert KD
    BJU Int; 2013 Mar; 111(3):485-91. PubMed ID: 22738331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medium-term experience of sacral neuromodulation by tined lead implantation.
    Van Voskuilen AC; Oerlemans DJ; Weil EH; van den Hombergh U; van Kerrebroeck PE
    BJU Int; 2007 Jan; 99(1):107-10. PubMed ID: 16956350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is the screening method of sacral neuromodulation a prognostic factor for long-term success?
    Marcelissen T; Leong R; Serroyen J; van Kerrebroeck P; de Wachter S
    J Urol; 2011 Feb; 185(2):583-7. PubMed ID: 21168865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy.
    Leong RK; De Wachter SG; Nieman FH; de Bie RA; van Kerrebroeck PE
    Neurourol Urodyn; 2011 Sep; 30(7):1249-52. PubMed ID: 21404317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychological and psychiatric factors as predictors for success in sacral neuromodulation treatment.
    Marcelissen TA; Leong RK; Nieman FH; van Lankveld JJ; van Kerrebroeck PE; de Wachter SG
    BJU Int; 2011 Dec; 108(11):1834-8. PubMed ID: 21810157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral caudal epidural neuromodulation for refractory urinary retention: a salvage procedure.
    Maher MG; Mourtzinos A; Zabihi N; Laiwalla UZ; Raz S; Rodríguez LV
    J Urol; 2007 Jun; 177(6):2237-40; discussion 2241. PubMed ID: 17509329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sacral nerve neuromodulation (InterStim). Part I: Review of the InterStim system.
    Rittenmeyer H
    Urol Nurs; 2008 Feb; 28(1):15-20. PubMed ID: 18335692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.